- Home
- RPRX vs TWLO Comparison
RPRX vs TWLO Comparison
Compare RPRX & TWLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- TWLO
- Stock Information
- Founded
- RPRX 1996
- TWLO 2008
- Country
- RPRX United States
- TWLO United States
- Employees
- RPRX N/A
- TWLO N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- TWLO Computer Software: Prepackaged Software
- Sector
- RPRX Health Care
- TWLO Technology
- Exchange
- RPRX Nasdaq
- TWLO Nasdaq
- Market Cap
- RPRX 15.6B
- TWLO 16.7B
- IPO Year
- RPRX 2020
- TWLO 2016
- Fundamental
- Price
- RPRX $37.03
- TWLO $106.66
- Analyst Decision
- RPRX Strong Buy
- TWLO Buy
- Analyst Count
- RPRX 4
- TWLO 26
- Target Price
- RPRX $44.50
- TWLO $132.42
- AVG Volume (30 Days)
- RPRX 3.5M
- TWLO 2.6M
- Earning Date
- RPRX 11-05-2025
- TWLO 10-30-2025
- Dividend Yield
- RPRX 2.38%
- TWLO N/A
- EPS Growth
- RPRX 54.86
- TWLO N/A
- EPS
- RPRX 2.32
- TWLO 0.13
- Revenue
- RPRX $2,305,243,000.00
- TWLO $4,729,372,000.00
- Revenue This Year
- RPRX $35.14
- TWLO $13.03
- Revenue Next Year
- RPRX $1.24
- TWLO $8.20
- P/E Ratio
- RPRX $15.92
- TWLO $841.50
- Revenue Growth
- RPRX 3.02
- TWLO 11.56
- 52 Week Low
- RPRX $24.05
- TWLO $69.40
- 52 Week High
- RPRX $38.00
- TWLO $151.95
- Technical
- Relative Strength Index (RSI)
- RPRX 61.20
- TWLO 49.41
- Support Level
- RPRX $35.23
- TWLO $105.71
- Resistance Level
- RPRX $36.36
- TWLO $111.69
- Average True Range (ATR)
- RPRX 0.63
- TWLO 4.82
- MACD
- RPRX 0.11
- TWLO 0.10
- Stochastic Oscillator
- RPRX 95.38
- TWLO 47.50
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About TWLO Twilio Inc.
Twilio is a cloud-based communications platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.